SEC FORM 3/A

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Berenstein Pierre A

(Last)

(First)

(Middle)

2202 N. WEST SHORE BLVD.

SUITE 500

(Street)

TAMPA

33607

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
04/23/2024

3. Issuer Name and Ticker or Trading Symbol
Bloomin' Brands, Inc. [ BLMN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, Chief Customer Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)
05/03/2024

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	23,230	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Restricted Stock Units	⁽¹⁾	⁽²⁾	Common Stock	8,007	$0⁽³⁾	D
Restricted Stock Units	⁽⁴⁾	⁽²⁾	Common Stock	10,730	$0⁽³⁾	D
Restricted Stock Units	⁽⁵⁾	⁽²⁾	Common Stock	2,536	$0⁽³⁾	D
Restricted Stock Units	⁽⁶⁾	⁽²⁾	Common Stock	2,954	$0⁽³⁾	D
Stock Option (right to buy)	⁽⁷⁾	01/17/2029	Common Stock	11,198	$19.23	D
Stock Option (right to buy)	⁽⁸⁾	06/01/2027	Common Stock	12,500	$20.38	D

Explanation of Responses:

1. On February 28, 2024, these restricted stock units ("RSUs") were granted in the original amount of 8,007, which vest in three equal annual installments, with a final vesting in 2027.

2. This field is not applicable.

3. Each RSU represents the contingent right to receive one share of common stock of the issuer upon vesting of the unit.

4. On August 1, 2023, these RSUs were granted in the original amount of 10,730, which vest in three equal annual installments, with a final vesting in 2026.

5. On February 22, 2023, these RSUs were granted in the original amount of 3,803, which vest in three equal annual installments, with a final vesting in 2026.

6. On February 21, 2022, these RSUs were granted in the original amount of 8,862, which vest in three equal annual installments, with a final vesting in 2025.

7. On January 17, 2019, these stock options were granted in the original amount of 22,395, which vest in four equal annual installments, with a final vesting in 2023.

8. On June 1, 2017, these stock options were granted in the original amount of 50,000, which vest in four equal annual installments, with a final vesting in 2021.

Remarks:

	/s/ Kelly Lefferts, Attorney in Fact	05/03/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.